Olema Pharmaceuticals
Organisation
Trials
Phase 3, Recruiting, 1,000 people, 25 Jul 2025
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Phase 1, Recruiting, 180 people, 20 Jan 2025
Phase 3, Active, not recruiting, 510 people, 30 Aug 2023
Phase 1, Active, not recruiting, 190 people, 19 Aug 2022
Phase 1, Active, not recruiting, 60 people, 4 Mar 2022
Sources: clinicaltrials.gov